JP1694480S - - Google Patents

Info

Publication number
JP1694480S
JP1694480S JPD2020-27421F JP2020027421F JP1694480S JP 1694480 S JP1694480 S JP 1694480S JP 2020027421 F JP2020027421 F JP 2020027421F JP 1694480 S JP1694480 S JP 1694480S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2020-27421F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2020-27421F priority Critical patent/JP1694480S/ja
Priority to US29/795,339 priority patent/USD968638S1/en
Application granted granted Critical
Publication of JP1694480S publication Critical patent/JP1694480S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2020-27421F 2020-12-18 2020-12-18 Active JP1694480S (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JPD2020-27421F JP1694480S (enExample) 2020-12-18 2020-12-18
US29/795,339 USD968638S1 (en) 2020-12-18 2021-06-17 Test chip

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2020-27421F JP1694480S (enExample) 2020-12-18 2020-12-18

Publications (1)

Publication Number Publication Date
JP1694480S true JP1694480S (enExample) 2021-09-06

Family

ID=77550405

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2020-27421F Active JP1694480S (enExample) 2020-12-18 2020-12-18

Country Status (2)

Country Link
US (1) USD968638S1 (enExample)
JP (1) JP1694480S (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA198103S (en) * 2020-07-29 2022-10-24 Testcard Ltd Test kit
CA198101S (en) * 2020-07-29 2022-10-24 Testcard Ltd Test kit
CA224341S (en) * 2023-02-24 2024-10-23 Flexxolutions Gfs B V Disinfection equipment for premises

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2034186T3 (es) * 1987-02-17 1993-04-01 Cmb Foodcan Plc Dispositivo de pruebas analiticas.
USD392391S (en) * 1996-02-23 1998-03-17 Mercury Diagnostics Inc. Disposable blood testing device
USD420141S (en) * 1998-12-15 2000-02-01 American Biomedica Corporation Drug test card
USD483496S1 (en) * 2000-06-28 2003-12-09 Bionor As Combined test unit and package for saliva and other fluids
USD477670S1 (en) * 2002-06-17 2003-07-22 Lifescan, Inc. Visual blood glucose test strip
KR100900511B1 (ko) * 2007-07-23 2009-06-03 주식회사 디지탈바이오테크놀러지 유체분석용 칩
USD694425S1 (en) * 2011-12-12 2013-11-26 Charm Sciences, Inc. Recognition test strip
USD800001S1 (en) * 2016-05-09 2017-10-17 Hach Company Water test strip
USD889684S1 (en) * 2018-05-29 2020-07-07 Boston Microfluidics, Inc Blood storage device
US20190374945A1 (en) * 2018-06-07 2019-12-12 General Automation Lab Technologies Inc. Method for assaying biological sample on microfabricated chip
USD895140S1 (en) * 2019-05-01 2020-09-01 Testcard Ltd. Medical test card
US11906515B2 (en) * 2019-05-31 2024-02-20 International Business Machines Corporation Multiplexed lateral flow assay device

Also Published As

Publication number Publication date
USD968638S1 (en) 2022-11-01

Similar Documents

Publication Publication Date Title
CL2025002368A1 (es) Proceso para la preparación de un inhibidor de cyp11a1 y sus intermedios
JP1694480S (enExample)
BR102021007058A2 (enExample)
BR102020022030A2 (enExample)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134206A1 (es) Degradantes y usos de los mismos
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134185A1 (es) Anticuerpos anti-receptor de transferrina y usos de estos
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos